Cargando…

Strategies in Gene Therapy for Glioblastoma

Glioblastoma (GBM) is the most aggressive form of brain cancer, with a dismal prognosis and extremely low percentage of survivors. Novel therapies are in dire need to improve the clinical management of these tumors and extend patient survival. Genetic therapies for GBM have been postulated and attem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwiatkowska, Aneta, Nandhu, Mohan S., Behera, Prajna, Chiocca, E. Antonio, Viapiano, Mariano S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875940/ https://www.ncbi.nlm.nih.gov/pubmed/24202446 http://dx.doi.org/10.3390/cancers5041271

Ejemplares similares

Tumor-derived fibulin-3 activates pro-invasive NF-kappa B signaling in glioblastoma cells and their microenvironment
por: Nandhu, Mohan Sobhana, et al.
Publicado: (2017)

BKM-120 (Buparlisib): A Phosphatidyl-Inositol-3 Kinase Inhibitor with Anti-Invasive Properties in Glioblastoma
por: Speranza, Maria-Carmela, et al.
Publicado: (2016)

The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling
por: Roshini, Arivazhagan, et al.
Publicado: (2022)

Gene- and viral-based therapies for brain tumors
por: Asadi-Moghaddam, Kaveh, et al.
Publicado: (2009)

Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
por: Caffery, Breanne, et al.
Publicado: (2019)

Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells
por: Godlewski, Jakub, et al.
Publicado: (2021)

Radiomics in the diagnosis of glioblastoma
por: Kwiatkowska-Miernik, Agnieszka, et al.
Publicado: (2023)

Proteomic Analysis Implicates Vimentin in Glioblastoma Cell Migration
por: Nowicki, Michal O., et al.
Publicado: (2019)

Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma
por: Verma, Jyoti, et al.
Publicado: (2014)

Hypoxic Roadmap of Glioblastoma—Learning about Directions and Distances in the Brain Tumor Environment
por: Bronisz, Agnieszka, et al.
Publicado: (2020)

Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping
por: Lyon, James F., et al.
Publicado: (2021)

Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme
por: Huang, Lei, et al.
Publicado: (2018)

Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus
por: Hollon, Todd C, et al.
Publicado: (2013)

Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy
por: Nakashima, Hiroshi, et al.
Publicado: (2015)

Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy
por: Alvarez-Breckenridge, Christopher A., et al.
Publicado: (2013)

Gene Targets of CAR-T Cell Therapy for Glioblastoma
por: Wang, Chaoqun, et al.
Publicado: (2023)

Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance
por: Nguyen, Ha S., et al.
Publicado: (2018)

Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance
por: Buccarelli, Mariachiara, et al.
Publicado: (2022)

Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
por: Hamad, Azzam, et al.
Publicado: (2023)

Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
por: Mozhei, Oleg, et al.
Publicado: (2020)

High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies
por: Ghiani, Lavinia, et al.
Publicado: (2022)

The small GTPase RhoG mediates glioblastoma cell invasion
por: Kwiatkowska, Aneta, et al.
Publicado: (2012)

Emerging treatment strategies for glioblastoma multiforme
por: Carlsson, Steven K, et al.
Publicado: (2014)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
por: Dapash, Mark, et al.
Publicado: (2021)

Immunotherapy for glioblastoma: the promise of combination strategies
por: Bausart, Mathilde, et al.
Publicado: (2022)

Glioblastoma Metabolism: Insights and Therapeutic Strategies
por: Bernhard, Chloé, et al.
Publicado: (2023)

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
por: Xu, Xin, et al.
Publicado: (2021)

Suppression of Peroxiredoxin 4 in Glioblastoma Cells Increases Apoptosis and Reduces Tumor Growth
por: Kim, Tae Hyong, et al.
Publicado: (2012)

The role of CMV in glioblastoma and implications for immunotherapeutic strategies
por: Rahman, Maryam, et al.
Publicado: (2018)

Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma
por: Ruiz-Garcia, Henry, et al.
Publicado: (2021)

Novel strategies in glioblastoma surgery aim at safe, supra-maximum resection in conjunction with local therapies
por: Wolbers, John G.
Publicado: (2014)

Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies
por: Fanelli, Giuseppe Nicolò, et al.
Publicado: (2021)

Glioblastoma: new therapeutic strategies to address cellular and genomic complexity
por: Cai, Xue, et al.
Publicado: (2017)

Modified Falling Mass Impact Test Performance on Functionally Graded Two Stage Aggregate Fibrous Concrete
por: Prasad, Nandhu, et al.
Publicado: (2021)

Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword
por: Blitz, Sarah E., et al.
Publicado: (2022)

Novel Therapies in Glioblastoma
por: Perry, James, et al.
Publicado: (2012)

Neurosurgical robotics: a review of brain and spine applications
por: Karas, Chris S., et al.
Publicado: (2007)

Molecular Strategies for RPGR Gene Therapy
por: Cehajic Kapetanovic, Jasmina, et al.
Publicado: (2019)

Advances in epigenetic glioblastoma therapy
por: Lee, Dong Hoon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hdj08c4c2b6n3sc5b1m7i0qap8